PubMed:29323748
Annnotations
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-126 | Sentence | denotes | The gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/β-catenin signaling pathway. |
T2 | 127-196 | Sentence | denotes | SHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. |
T3 | 197-322 | Sentence | denotes | Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. |
T4 | 323-425 | Sentence | denotes | In addition, the mutation rate for SHP2 is the highest for colorectal cancer (CRC) among solid tumors. |
T5 | 426-613 | Sentence | denotes | The E76K GOF mutation is the most common and active SHP2 mutation; however, the pathogenic effects and function of this mutation in CRC tumor progression have not been well characterized. |
T6 | 614-756 | Sentence | denotes | The Wnt/β-catenin (CTNNB1) signaling pathway is crucial for CRC, and excessive activation of this pathway has been observed in several tumors. |
T7 | 757-976 | Sentence | denotes | We used Ptpn11E76K conditional knock-in mice to study this GOF mutation in colitis-associated CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/β-catenin signaling. |
T8 | 977-1080 | Sentence | denotes | Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. |
T9 | 1081-1256 | Sentence | denotes | In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/β-catenin signaling pathway. |
T10 | 1257-1374 | Sentence | denotes | Together, our results showed that SHP2E76K acts as an oncogene that promotes the tumorigenesis and metastasis of CRC. |
T1 | 0-126 | Sentence | denotes | The gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/β-catenin signaling pathway. |
T2 | 127-196 | Sentence | denotes | SHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. |
T3 | 197-322 | Sentence | denotes | Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. |
T4 | 323-425 | Sentence | denotes | In addition, the mutation rate for SHP2 is the highest for colorectal cancer (CRC) among solid tumors. |
T5 | 426-613 | Sentence | denotes | The E76K GOF mutation is the most common and active SHP2 mutation; however, the pathogenic effects and function of this mutation in CRC tumor progression have not been well characterized. |
T6 | 614-756 | Sentence | denotes | The Wnt/β-catenin (CTNNB1) signaling pathway is crucial for CRC, and excessive activation of this pathway has been observed in several tumors. |
T7 | 757-976 | Sentence | denotes | We used Ptpn11E76K conditional knock-in mice to study this GOF mutation in colitis-associated CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/β-catenin signaling. |
T8 | 977-1080 | Sentence | denotes | Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. |
T9 | 1081-1256 | Sentence | denotes | In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/β-catenin signaling pathway. |
T10 | 1257-1374 | Sentence | denotes | Together, our results showed that SHP2E76K acts as an oncogene that promotes the tumorigenesis and metastasis of CRC. |
kaiyin_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 4-20 | PosReg | denotes | gain-of-function |
T2 | 30-34 | Var | denotes | E76K |
T1 | 38-42 | Gene | denotes | SHP2 |
T4 | 43-51 | PosReg | denotes | promotes |
T36 | 52-55 | Disease | denotes | CAC |
T37 | 56-69 | CPA | denotes | tumorigenesis |
T10 | 74-81 | PosReg | denotes | induces |
T11 | 82-85 | CPA | denotes | EMT |
T42 | 94-125 | Pathway | denotes | Wnt/β-catenin signaling pathway |
T38 | 340-348 | Var | denotes | mutation |
T39 | 358-362 | Gene | denotes | SHP2 |
T41 | 370-377 | Reg | denotes | highest |
T40 | 382-399 | Disease | denotes | colorectal cancer |
T23 | 977-983 | Gene | denotes | Ptpn11 |
T24 | 983-987 | Var | denotes | E76K |
T25 | 1024-1034 | PosReg | denotes | aggravated |
T26 | 1035-1047 | CPA | denotes | inflammation |
T27 | 1052-1061 | PosReg | denotes | increased |
T28 | 1062-1065 | Disease | denotes | CAC |
T29 | 1066-1079 | CPA | denotes | tumorigenesis |
T30 | 1091-1095 | Gene | denotes | SHP2 |
T31 | 1095-1099 | Var | denotes | E76K |
T32 | 1111-1119 | PosReg | denotes | promoted |
T33 | 1120-1163 | CPA | denotes | malignant biological behaviors of CRC cells |
T34 | 1168-1175 | PosReg | denotes | induced |
T35 | 1176-1215 | CPA | denotes | epithelial-mesenchymal transition (EMT) |
T21 | 1291-1295 | Gene | denotes | SHP2 |
T22 | 1295-1299 | Var | denotes | E76K |
T17 | 1325-1333 | PosReg | denotes | promotes |
T18 | 1338-1351 | CPA | denotes | tumorigenesis |
T19 | 1356-1366 | CPA | denotes | metastasis |
T20 | 1370-1373 | Disease | denotes | CRC |
R1 | T1 | T2 | ThemeOf | SHP2,E76K |
R10 | T24 | T25 | CauseOf | E76K,aggravated |
R11 | T26 | T25 | ThemeOf | inflammation,aggravated |
R12 | T24 | T27 | CauseOf | E76K,increased |
R15 | T30 | T31 | ThemeOf | SHP2,E76K |
R16 | T31 | T32 | CauseOf | E76K,promoted |
R17 | T31 | T34 | CauseOf | E76K,induced |
R18 | T33 | T32 | ThemeOf | malignant biological behaviors of CRC cells,promoted |
R19 | T35 | T34 | ThemeOf | epithelial-mesenchymal transition (EMT),induced |
R2 | T2 | T3 | CauseOf | E76K,gain-of-function |
R20 | T21 | T22 | ThemeOf | SHP2,E76K |
R21 | T22 | T17 | CauseOf | E76K,promotes |
R22 | T18 | T17 | ThemeOf | tumorigenesis,promotes |
R23 | T19 | T17 | ThemeOf | metastasis,promotes |
R24 | T20 | T19 | ThemeOf | CRC,metastasis |
R25 | T20 | T18 | ThemeOf | CRC,tumorigenesis |
R26 | T29 | T27 | ThemeOf | tumorigenesis,increased |
R27 | T28 | T29 | ThemeOf | CAC,tumorigenesis |
R28 | T36 | T37 | ThemeOf | CAC,tumorigenesis |
R29 | T37 | T4 | ThemeOf | tumorigenesis,promotes |
R3 | T3 | T4 | CauseOf | gain-of-function,promotes |
R30 | T39 | T38 | ThemeOf | SHP2,mutation |
R31 | T38 | T41 | CauseOf | mutation,highest |
R32 | T40 | T41 | ThemeOf | colorectal cancer,highest |
R33 | T42 | T10 | ThemeOf | Wnt/β-catenin signaling pathway,induces |
R7 | T11 | T10 | ThemeOf | EMT,induces |
R8 | T3 | T10 | CauseOf | gain-of-function,induces |
R9 | T23 | T24 | ThemeOf | Ptpn11,E76K |
name_no
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 4-20 | PosReg | denotes | gain-of-function |
T2 | 30-34 | Var | denotes | E76K |
T1 | 38-42 | Gene | denotes | SHP2 |
T4 | 43-51 | PosReg | denotes | promotes |
T36 | 52-55 | Disease | denotes | CAC |
T37 | 56-69 | CPA | denotes | tumorigenesis |
T10 | 74-81 | PosReg | denotes | induces |
T11 | 82-85 | CPA | denotes | EMT |
T42 | 94-125 | Pathway | denotes | Wnt/β-catenin signaling pathway |
T38 | 340-348 | Var | denotes | mutation |
T39 | 358-362 | Gene | denotes | SHP2 |
T41 | 370-377 | Reg | denotes | highest |
T40 | 382-399 | Disease | denotes | colorectal cancer |
T23 | 977-983 | Gene | denotes | Ptpn11 |
T24 | 983-987 | Var | denotes | E76K |
T25 | 1024-1034 | PosReg | denotes | aggravated |
T26 | 1035-1047 | CPA | denotes | inflammation |
T27 | 1052-1061 | PosReg | denotes | increased |
T28 | 1062-1065 | Disease | denotes | CAC |
T29 | 1066-1079 | CPA | denotes | tumorigenesis |
T30 | 1091-1095 | Gene | denotes | SHP2 |
T31 | 1095-1099 | Var | denotes | E76K |
T32 | 1111-1119 | PosReg | denotes | promoted |
T33 | 1120-1163 | CPA | denotes | malignant biological behaviors of CRC cells |
T34 | 1168-1175 | PosReg | denotes | induced |
T35 | 1176-1215 | CPA | denotes | epithelial-mesenchymal transition (EMT) |
T21 | 1291-1295 | Gene | denotes | SHP2 |
T22 | 1295-1299 | Var | denotes | E76K |
T17 | 1325-1333 | PosReg | denotes | promotes |
T18 | 1338-1351 | CPA | denotes | tumorigenesis |
T19 | 1356-1366 | CPA | denotes | metastasis |
T20 | 1370-1373 | Disease | denotes | CRC |
R1 | T1 | T2 | ThemeOf | SHP2,E76K |
R10 | T24 | T25 | CauseOf | E76K,aggravated |
R11 | T26 | T25 | ThemeOf | inflammation,aggravated |
R12 | T24 | T27 | CauseOf | E76K,increased |
R15 | T30 | T31 | ThemeOf | SHP2,E76K |
R16 | T31 | T32 | CauseOf | E76K,promoted |
R17 | T31 | T34 | CauseOf | E76K,induced |
R18 | T33 | T32 | ThemeOf | malignant biological behaviors of CRC cells,promoted |
R19 | T35 | T34 | ThemeOf | epithelial-mesenchymal transition (EMT),induced |
R2 | T2 | T3 | CauseOf | E76K,gain-of-function |
R20 | T21 | T22 | ThemeOf | SHP2,E76K |
R21 | T22 | T17 | CauseOf | E76K,promotes |
R22 | T18 | T17 | ThemeOf | tumorigenesis,promotes |
R23 | T19 | T17 | ThemeOf | metastasis,promotes |
R24 | T20 | T19 | ThemeOf | CRC,metastasis |
R25 | T20 | T18 | ThemeOf | CRC,tumorigenesis |
R26 | T29 | T27 | ThemeOf | tumorigenesis,increased |
R27 | T28 | T29 | ThemeOf | CAC,tumorigenesis |
R28 | T36 | T37 | ThemeOf | CAC,tumorigenesis |
R29 | T37 | T4 | ThemeOf | tumorigenesis,promotes |
R3 | T3 | T4 | CauseOf | gain-of-function,promotes |
R30 | T39 | T38 | ThemeOf | SHP2,mutation |
R31 | T38 | T41 | CauseOf | mutation,highest |
R32 | T40 | T41 | ThemeOf | colorectal cancer,highest |
R33 | T42 | T10 | ThemeOf | Wnt/β-catenin signaling pathway,induces |
R7 | T11 | T10 | ThemeOf | EMT,induces |
R8 | T3 | T10 | CauseOf | gain-of-function,induces |
R9 | T23 | T24 | ThemeOf | Ptpn11,E76K |